Fudan University Wang Weibing Research Team
Introduction of team's institution
The School of Public Health of Fudan University, founded in 1928, is the earliest university of its kind in China and has long been a national leader of public health. The school’s Department of Social Medicine and Health Administration, established in 1982, is a key entity operating in the field of public health in China. In 2004, the University became a Phase II Innovation Research Base of the Ministry of Education and established the Key Laboratory of Medical Technology Assessment of the Ministry of Health. The University has established four policy research and practice bases in Suzhou, Shandong, Shanghai, and Hebei Province, and trained more than a thousand health managers all over China.
The Department of Epidemiology of the School of Public Health of Fudan University was founded in 1952 by the late Professor Su Delong, a famous epidemiologist in China, and is one of the first batch of doctoral degree awarding sites in China, a key discipline of the state and Shanghai, and a key construction discipline of the “985” and “211” projects of Fudan University. Through the efforts of several generations of epidemiologists, the discipline has established research teams for tropical diseases (schistosomiasis), tuberculosis, AIDS, influenza, viral hepatitis, chronic non-communicable diseases, etc., forming a relatively stable research direction. It is in a leading position in the research fields of COVID-19, hand, foot and mouth disease, schistosomiasis, tuberculosis, AIDS and other infectious disease epidemiology.
Team members
Prof. Weibing Wang, Director of Epidemiology Department, School of Public Health, Fudan University, PhD supervisor, serves as the main committee member of the Shanghai Preventive Medicine Association Epidemiology Branch, vice-chairman of the Field Epidemiology Group of Public Health Branch of Chinese Medical Association, deputy director of the Advisory Committee of International Vaccine and Health Research Collaboration Platform of Shenzhen Medical Academy of Research, executive member of Chinese Anti-Tuberculosis Association Geriatric Branch, member of National Expert Guidance Group on Abnormal Reactions to Vaccination and Compensation Insurance Work. Member of the Expert Steering Group of National Vaccination Abnormal Reaction Compensation Insurance Work, etc. He has published more than 100 SCI papers and has undertaken or participated in a number of international and domestic projects, including the sub-projects of the National 13th Five-Year Plan Major Project on Infectious Diseases, National Natural Science Foundation of China (NSFC) project, WHO special project, joint project of the Swedish International Development Agency (SIDA), and donation project of the Gates Foundation. The research results of TB deaths relying on the Shanghai TB cohort population were selected as one of the top ten national hotspots of medical research in 2017.
Representative achievements of the team in the past five years
Liu Z, Li M, Hutton DW, Wagner AL, Yao Y, Zhu W, Cao L, Tang S, Pan J, Wang Y, Zhao Q, Ren H, Wang Y, Wang W*. Impact of the national hepatitis B immunization program in China: a modeling study. Infect Dis Poverty. 2022 Oct 11;11(1):106. doi: 10.1186/s40249-022-01032-5. PMID: 36221140; PMCID: PMC9552421.
Zhu Y, Peng L, Li H, Pan J, Kan H, Wang W*. Temporal variations of short-term associations between PM10 and NO2 concentrations and emergency department visits in Shanghai, China 2008-2019. Ecotoxicol Environ Saf. 2022 Jan 1; 229:113087. doi: 10.1016/j.ecoenv.2021.113087. Epub 2021 Dec 15. PMID: 34922167.
Zhu W, Zhang M, Pan J, Yao Y*, Wang W*. Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study. BMC Med. 2021 Dec 7;19(1):308. doi: 10.1186/s12916-021-02178-z. PMID: 34872559; PMCID: PMC8648499.
Pan J, Wang Y, Cao L, Wang Y, Zhao Q, Tang S, Gong W, Guo L, Liu Z, Wen Z, Zheng B, Wang W*. Impact of immunization programs on 11 childhood vaccine-preventable diseases in China: 1950-2018. Innovation (Camb). 2021 May 5;2(2):100113. doi: 10.1016/j.xinn.2021.100113. PMID: 34557762; PMCID: PMC8454656.
Pan J, Yao Y, Liu Z, Meng X, Ji JS, Qiu Y, Wang W, Zhang L, Wang W*, Kan H*. Warmer weather unlikely to reduce the COVID-19 transmission: An ecological study in 202 locations in 8 countries. Sci Total Environ. 2021 Jan 20; 753:142272. doi: 10.1016/j.scitotenv.2020.142272. Epub 2020 Sep 9. PMID: 33207446; PMCID: PMC7480263.
Yao Y, Pan J, Liu Z, Meng X, Wang W, Kan H*, Wang W*. Ambient nitrogen dioxide pollution and spreadability of COVID-19 in Chinese cities. Ecotoxicol Environ Saf. 2021 Jan 15; 208:111421. doi: 10.1016/j.ecoenv.2020.111421. Epub 2020 Sep 30. PMID: 33038729; PMCID: PMC7524685.
Zhixi Liu, Mengying Li, Yue Wang, Qi Zhao, Ying Wang, Wang W*. Impact and cost-effectiveness of national Hepatitis B immunization program in China: a modeling study. Lancet 2020, 396: S11. doi: 10.1016/S0140-6736(20)32431-4
Yao Y, Pan J, Liu Z, Meng X, Wang W, Kan H*, Wang W*. Temporal association between particulate matter pollution and case fatality rate of COVID-19 in Wuhan. Environ Res. 2020 Oct; 189:109941. doi: 10.1016/j.envres.2020.109941. Epub 2020 Jul 15. PMID: 32678728; PMCID: PMC7361083.
Yao Y, Pan J, Liu Z, Meng X, Wang W, Kan H, Wang W*. No association of COVID-19 transmission with temperature or UV radiation in Chinese cities. Eur Respir J. 2020 May 7;55(5):2000517. doi: 10.1183/13993003.00517-2020. PMID: 32269084; PMCID: PMC7144256.
Wang Y, Wang W*. Importance of tuberculosis vaccination targeting older people in China. Lancet Glob Health. 2019 Feb;7(2): e165-e166. doi: 10.1016/S2214-109X (18)30480-7. Epub 2019 Jan 7. PMID: 30630774.
*Corresponding Author
Related projects
Other teams
